Semble Gains $15M in Series B

Semble, a UK-based healthtech SaaS company, has raised $15 million in Series B funding, bringing its total raised to $27 million. This investment aims to enhance Semble’s capabilities and expand its footprint in the UK and France, addressing the urgent need for modernized healthcare IT systems.

• Funding Details: Semble raised $15 million in Series B funding. The round was led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures, and Triple Point.

• Innovative Solutions: The company focuses on workflow automation and AI-driven solutions to enhance patient care and operational efficiency.

• Founder's Vision: CEO Christoph Lippuner emphasized the importance of empowering healthcare professionals to focus on patient care, stating that outdated systems have long detracted from their work.

• Support from Investors: Alex Gwyther of Mercia Ventures highlighted the threat posed by legacy systems in healthcare, asserting that Semble is leading the charge in developing an all-in-one clinical system to automate operations.

The company's commitment to driving innovation positions it as a key player in the evolving landscape of healthtech.